SNYR

Conviction 0HealthcareScan · Mon, Aug 10, 2026

Inverted hammer

SNYR$0.1658-1.54%

ResistanceSupportVol 14

Vol MA14 213.69K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Synergy CHC Corp.Medicinal Chemicals & Botanical Productswww.synergychc.com ↗

Price0.1658

Change-1.54%

Gap-1.60%

Rel volume0.46×

Avg volume190.3K

Avg $ vol33.35K

SMA 200.1769

SMA 500.1988

SMA 2001.12

Price vs 50-16.62%

Price vs 200-85.18%

MA stackbearish

50/200 cross—

Supertrenddown · 0.1934

RSI (14)35

MACD hist0.00

MACD cross—

Stoch %K / %D20 / 20

ADX (14)26

+DI / −DI14 / 30

RSI divergence—

MACD divergence—

ATR %+6.44%

ADR %4.75%

52w high3.92

52w low0.1639

From 52w high-95.77%

Above 52w low+1.16%

New 52w highNo

SqueezeOn · 2d

Bollinger width23.30%

%B0.23

Donchian pos12.27%

Donchian high0.1994

Donchian low0.1611

AVWAP (52w high)0.4825

vs AVWAP high-65.64%

AVWAP (52w low)0.1708

vs AVWAP low-2.90%

OBV trendFlat

Chaikin MF (20)0.02

Today vs 20d0.46×

Avg vol (14d)213.69K

Avg vol (20d)190.3K

Avg $ vol (20d)33.35K

Market cap2.47M

RS 3m (vs SPY)-63.13%

RS 6m (vs SPY)-104.32%

RS line new highNo

Trend template0/8

Technical rank4.0

1 week-5.47%

1 month-19.63%

3 months-57.54%

6 months-90.63%

1 year-95.43%

YTD-91.18%

P/E-0.20

P/B-0.10

P/S0.08

P/FCF-0.91

EPS-1.27

Div yield47.52%

ROE48.58%

ROA-190.99%

Debt/Eq-1.14

Current0.93

EV/EBITDA-3.75

Gross margin69.16%

Net margin-42.04%

Rev growth-13.21%

EPS growth-680.77%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value31.2M

Revenue6.12M

Net income-2.57M

Gross profit3.97M

Free cash flow-2.71M

IndustryMedicinal Chemicals & Botanical Products

ExchangeNasdaq

Shares out15.08M

Employees28

ListedThu, Nov 7, 2013

Free float7.97M

Float %53.9%

Short interest79.21K

Days to cover0.4d

Short volume39.3%

Squeeze score4 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.23 vs $0.03

Last surprise-866.7% miss

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank4.0 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmInverted hammer

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SNYR

All disclosures →

No recent disclosed trades by Congress in SNYR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SNYR · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Kaushal Nitin Director · Common Stock, par value $0.00001 per share · 2026-04-21	Grant	306.43K	$0	2026-04-21	2026-04-24
Thompson Teresa Brigid Director · Common Stock, par value $0.00001 per share · 2026-04-21	Grant	25.82K	$0	2026-04-21	2026-04-23

SEC filings

EDGAR filings in SNYR · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.